Skip to content
  • Report Harm
  • Newsletter
  • Press Room
Facebook Linkedin YouTube Instagram Twitter Spotify
Benzodiazepine Information Coalition
  • About BenzodiazepinesExpand
    • Benzo BasicsExpand
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions and Lawsuits—and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Xanax Study Outcomes
    • Benzo Stories
    • PrescribingExpand
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing RisksExpand
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • DeprescribingExpand
      • Ashton Manual
      • Tapering Strategies and Solutions
      • Detox, Cold Turkey, Abrupt Cessation
      • Estimates of Withdrawal
      • How To Find Tapering Help
      • Dosages Prevent Safe Withdrawal
      • Why Patients Shouldn’t Go To Detox or Rehab
    • Desprescribing RisksExpand
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special PopulationsExpand
      • Benzodiazepines and PTSD
      • Celebrities
      • COVID-19
      • Elderly
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About UsExpand
    • Our Mission
    • Board Members and Advisors
    • Press Room
    • Receive Our Newsletter
    • FAQs
    • VolunteerExpand
      • Informed Consent Policy
      • FDA Reporting Program
      • Share Your Story!
      • Media Interview List Registration
    • Contact Us
  • Our ImpactExpand
    • Media Outreach
    • Podcasts
    • Programs and Projects
    • Research and Publications
    • Speaking and Events
    • Quarterly Updates
    • Upcoming Events
  • ResourcesExpand
    • Ashton Manual
    • Benzodiazepine Tapering Strategies and Solutions
    • Financial and Disability Information
    • How To Find Tapering Help
    • Support
    • Information
    • Benzodiazepine Cooperative Providers
  • Blog
  • Donate
Donate
Facebook Linkedin Twitter Instagram YouTube
Benzodiazepine Information Coalition

Suicide

If you are suicidal please contact a suicide hotline or your local emergency medical services for help as soon as possible. We acknowledge that many benzodiazepine harmed individuals are afraid to seek medical assistance for suicidality because they fear they will be disbelieved or harmed further due to medicine’s insufficient training regarding the severity and proper management of benzodiazepine harm.

In addition to suicidality being a possible symptom of benzodiazepine withdrawal syndrome (BWS), for some, benzodiazepine prescription can create or worsen depression as they are central nervous system depressants. While benzodiazepines are often prescribed for mixed anxiety-depression diagnoses, the pre-existing depression may be exacerbated by the addition of the benzodiazepine. They also may create a new onset of depression in people who have no prior history of depression, which may result in suicidal ideation or a suicide attempt.

Stopping benzodiazepines can also increase depression, suicidal ideation and suicidal action. Professor C. Heather Ashton conducted a clinical outcome assessment of 50 patients in her withdrawal clinic. Of 50 patients, 10 had taken drug overdoses requiring hospital admission. Of those 10 patients just 2 had a history of depression prior to being prescribed benzodiazepines. In her post-withdrawal follow up she reported that in all cases the depression subsided with no further overdoses in the 10-month to 3.5 year follow-up period after withdrawal.

It is important to note that some of the patients who have chronic depression, who feel suicidal or who attempt suicide while taking the benzodiazepines long-term, are completely unaware that the benzodiazepines are the actual cause. The patients experiencing adverse or withdrawal effects are often misdiagnosed, when seeking help, with “refractory depression” missing the benzodiazepine as the true cause they’ve been prescribed. The outcome for these patients is often bleak.

The Committee on Safety of Medicines in the UK recommended in 1988 that “benzodiazepines should not be used alone to treat depression or anxiety associated with depression. Suicide may be precipitated in such patients.

The Committee also offered the following precaution:

Disinhibiting effects may be manifested in various ways. Suicide may be precipitated in patients who are depressed, and aggressive behaviour towards self and others may be precipitated. Extreme caution should therefore be used in prescribing benzodiazepines in patients with personality disorders.

Similarly, a literature review concluded:

Benzodiazepines appear to cause an overall increased risk of attempting or completing suicide. Possible mechanisms of prosuicidal effects may include increases in impulsivity or aggression, rebound or withdrawal symptoms, and toxicity in overdose.

Also, benzodiazepines are responsible for causing emotional blunting or “emotional anesthesia” (inability to feel pleasure or pain) and anhedonia (an inability to feel pleasure) both while taking the drugs, particularly long-term (past 2-4 weeks), and while in withdrawal from the drugs. Such effects are probably related to the inhibitory effect of benzodiazepines on activity in emotional centers in the brain. Once patients withdraw and heal from the neurochemical and neural structure changes brought on by the benzodiazepines, they often express great regret at their lack of emotional responses to family members, like their children or spouses, during the period of time that they were taking the drugs and in withdrawal from them. Taking benzodiazepines long-term (past 2-4 weeks) can also contribute to domestic disharmony and dissolutions of marriage as a result. The Committee on Safety of Medicines in the UK cautions:

Anecdotally, in the benzodiazepine withdrawal support communities, there have been numerous completed suicides by people either having adverse effects (paradoxical reactions, interdose, tolerance, etc.) or by those attempting withdrawal or who had fully withdrawn, especially those who developed akathisia during cessation. Many times, these people have withdrawn too quickly initiating a severe benzodiazepine withdrawal syndrome which put them in grave persistent distress.

Compounding the issue, many patients having adverse effects of withdrawing from benzodiazepines report feeling hopeless due to feeling invalidated, disbelieved and/or dismissed by the medical community and/or their families and friends. It is for this reason that these patients don’t call suicide hotlines or reach out for help; they know there is little specialized help available for their problem and they fear that they will be disbelieved, involuntarily placed into a mental institution, and/or drugged further with more physical dependence- and withdrawal-causing psychotropic drugs which could worsen their already grave condition.

This is why it is very important that the medical community gets quickly educated on benzodiazepine tolerance, interdose withdrawal, adverse events, withdrawal syndromes, and proper withdrawal protocols and that proper support measures for these patients be implemented. Unrecognitzed and mismanaged adverse affects from this class of drugs is killing patients in the taken-as-prescribed population, it’s not typically due to abuse, accidental overdose, or combining them with opiates or alcohol —it’s often due to suicide. The withdrawal symptoms or adverse effects are sometimes so severe that the people tasked with enduring them can simply no longer cope for as long as it takes (for a percentage of people, the syndrome can become protracted and persist for years) for the downregulated 

GABA and benzodiazepine receptors to upregulate, or to heal, from the benzo-inflicted changes and damage.

Read more:

Want to Prevent suicide? Stop Ignoring Benzo Patients

How My Bipolar Treatment Disabled Me and Drove Me to Suicide

Christine’s Story: Ativan, Withdrawal, Akathisia and Suicide

Benzodiazepines and Suicide

Contact Us

Inquiries
bic@benzoinfo.com

As an awareness organization, we do not offer any support services or guidance. See our resources for services and support.

Mailing Address
1042 Ft. Union Blvd, PMB 1030
Midvale, Utah 84047

Support BIC

We were formed to change the lack of knowledge in the public and the medical system. But we cannot do it alone. We rely solely on donations to operate. We are a 501(c)(3) tax exempt organization.

DONATE

Newsletter

Get notified about the latest studies, updates, calls to action, media stories, and other information.

*

IMPORTANT: After signing up, check your email to confirm we have the correct address. If you do not see an email, check your spam. We will add you to our newsletter once you complete this step to ensure delivery.

Notices

Benzodiazepine Information Coalition is a 501(c)3 tax exempt organization.

EIN: 81-3442343

Privacy Policy
Medical Disclaimer
Terms and Conditions
Free Charity Hosting by Kualo

Facebook Linkedin YouTube Instagram Twitter Spotify

© 2023 Benzodiazepine Information Coalition

Scroll to top
  • About Benzodiazepines
    • Benzo Basics
      • Ashton Manual
      • A Brief History Of Benzodiazepines
      • Class Actions and Lawsuits—and Reporting Harm 
      • FDA 2020 Benzodiazepine Boxed Warning
      • Medications and Supplements of Concern
      • Xanax Study Outcomes
    • Benzo Stories
    • Prescribing
      • Addiction vs Physical Dependence
      • Genetic Testing
      • Informed Consent
      • Low Dose Benzodiazepines
      • Mechanism of Action
      • Prescribing Statistics
      • Steps to Reduce Benzodiazepine Overprescribing
      • Therapeutic Actions
    • Prescribing Risks
      • Akathisia
      • Fluoroquinolones
      • Functional Brain Changes
      • Interdose Withdrawal
      • Paradoxical Reactions
      • Physical Dependence
      • Risks of Remaining on Benzodiazepines
      • Red Flags
      • Short-Term Risks
      • Side Effects
      • Suicide
      • Tolerance
    • Deprescribing
      • Ashton Manual
      • Tapering Strategies and Solutions
      • Detox, Cold Turkey, Abrupt Cessation
      • Estimates of Withdrawal
      • How To Find Tapering Help
      • Dosages Prevent Safe Withdrawal
      • Why Patients Shouldn’t Go To Detox or Rehab
    • Desprescribing Risks
      • Akathisia
      • Benzodiazepine Withdrawal Syndrome (BWS)
      • Forced Switching or Stopping
      • Functional Brain Changes
      • Kindling
      • Protracted Withdrawal Syndrome (PWS)
      • Suicide
      • Withdrawal & Post Withdrawal Symptoms
    • Special Populations
      • Benzodiazepines and PTSD
      • Celebrities
      • COVID-19
      • Elderly
      • Women
      • Incarcerated Population
      • Substance Use Disorders
  • About Us
    • Our Mission
    • Board Members and Advisors
    • Press Room
    • Receive Our Newsletter
    • FAQs
    • Volunteer
      • Informed Consent Policy
      • FDA Reporting Program
      • Share Your Story!
      • Media Interview List Registration
    • Contact Us
  • Our Impact
    • Media Outreach
    • Podcasts
    • Programs and Projects
    • Research and Publications
    • Speaking and Events
    • Quarterly Updates
    • Upcoming Events
  • Resources
    • Ashton Manual
    • Benzodiazepine Tapering Strategies and Solutions
    • Financial and Disability Information
    • How To Find Tapering Help
    • Support
    • Information
    • Benzodiazepine Cooperative Providers
  • Blog
  • Donate
Search
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset